243 related articles for article (PubMed ID: 15861394)
1. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways.
Davies M; Robinson M; Smith E; Huntley S; Prime S; Paterson I
J Cell Biochem; 2005 Aug; 95(5):918-31. PubMed ID: 15861394
[TBL] [Abstract][Full Text] [Related]
2. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.
Rhyu DY; Yang Y; Ha H; Lee GT; Song JS; Uh ST; Lee HB
J Am Soc Nephrol; 2005 Mar; 16(3):667-75. PubMed ID: 15677311
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of Smad transactivation by Jun proteins during a combined treatment with epidermal growth factor and transforming growth factor-beta in rat hepatocytes. role of phosphatidylinositol 3-kinase-induced AP-1 activation.
Peron P; Rahmani M; Zagar Y; Durand-Schneider AM; Lardeux B; Bernuau D
J Biol Chem; 2001 Mar; 276(13):10524-31. PubMed ID: 11134003
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition.
Valcourt U; Kowanetz M; Niimi H; Heldin CH; Moustakas A
Mol Biol Cell; 2005 Apr; 16(4):1987-2002. PubMed ID: 15689496
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
[TBL] [Abstract][Full Text] [Related]
7. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway.
Yue J; Mulder KM
J Biol Chem; 2000 Oct; 275(40):30765-73. PubMed ID: 10843986
[TBL] [Abstract][Full Text] [Related]
8. Regulation of transforming growth factor-β1-dependent integrin β6 expression by p38 mitogen-activated protein kinase in bile duct epithelial cells.
Sullivan BP; Kassel KM; Manley S; Baker AK; Luyendyk JP
J Pharmacol Exp Ther; 2011 May; 337(2):471-8. PubMed ID: 21303922
[TBL] [Abstract][Full Text] [Related]
9. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition.
Zavadil J; Cermak L; Soto-Nieves N; Böttinger EP
EMBO J; 2004 Mar; 23(5):1155-65. PubMed ID: 14976548
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling.
Dai C; Yang J; Liu Y
J Biol Chem; 2003 Apr; 278(14):12537-45. PubMed ID: 12560323
[TBL] [Abstract][Full Text] [Related]
11. Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro.
Brown KA; Aakre ME; Gorska AE; Price JO; Eltom SE; Pietenpol JA; Moses HL
Breast Cancer Res; 2004; 6(3):R215-31. PubMed ID: 15084245
[TBL] [Abstract][Full Text] [Related]
12. Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas.
Iglesias M; Frontelo P; Gamallo C; Quintanilla M
Oncogene; 2000 Aug; 19(36):4134-45. PubMed ID: 10962574
[TBL] [Abstract][Full Text] [Related]
13. PAI-1 mediates the TGF-beta1+EGF-induced "scatter" response in transformed human keratinocytes.
Freytag J; Wilkins-Port CE; Higgins CE; Higgins SP; Samarakoon R; Higgins PJ
J Invest Dermatol; 2010 Sep; 130(9):2179-90. PubMed ID: 20428185
[TBL] [Abstract][Full Text] [Related]
14. Critical role of Smads and AP-1 complex in transforming growth factor-beta -dependent apoptosis.
Yamamura Y; Hua X; Bergelson S; Lodish HF
J Biol Chem; 2000 Nov; 275(46):36295-302. PubMed ID: 10942775
[TBL] [Abstract][Full Text] [Related]
15. Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase.
Wang D; Shen Q; Chen YQ; Wang MH
Oncogene; 2004 Mar; 23(9):1668-80. PubMed ID: 15001985
[TBL] [Abstract][Full Text] [Related]
16. Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer.
Park BJ; Park JI; Byun DS; Park JH; Chi SG
Cancer Res; 2000 Jun; 60(11):3031-8. PubMed ID: 10850453
[TBL] [Abstract][Full Text] [Related]
17. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta (TGF-beta) activates cytosolic phospholipase A2alpha (cPLA2alpha)-mediated prostaglandin E2 (PGE)2/EP1 and peroxisome proliferator-activated receptor-gamma (PPAR-gamma)/Smad signaling pathways in human liver cancer cells. A novel mechanism for subversion of TGF-beta-induced mitoinhibition.
Han C; Demetris AJ; Liu Y; Shelhamer JH; Wu T
J Biol Chem; 2004 Oct; 279(43):44344-54. PubMed ID: 15294900
[TBL] [Abstract][Full Text] [Related]
19. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
20. Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells.
Kim HS; Luo L; Pflugfelder SC; Li DQ
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):840-8. PubMed ID: 15728539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
